Asep Medical Holdings IncCanadian Securities Exchange:ASEPView on OTC Pink - Current Information
- LAST PRICE0.0600
- TODAY'S CHANGE (%)0.0200 (50.0000%)
- Bid / Lots0.0400/ 15
- Ask / Lots0.0600/ 24
- Open / Previous Close0.0400 / 0.0400
- Day Range
- 52 Week Range
- Volume110,874
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | ASEP |
|---|---|---|
| 09:32 ET | 20000 | 0.04 |
| 10:58 ET | 8000 | 0.05 |
| 11:32 ET | 5000 | 0.05 |
| 12:26 ET | 25000 | 0.05 |
| 03:24 ET | 52000 | 0.06 |
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Asep Medical Holdings Inc | 4.5M | -0.8x | --- |
Revive Therapeutics Ltd | 4.2M | -0.7x | --- |
Awakn Life Sciences Corp | 4.6M | -1.2x | --- |
Rakovina Therapeutics Inc | 5.0M | -1.3x | --- |
Quest Pharmatech Inc | 5.1M | 0.4x | --- |
GeneTether Therapeutics Inc | 3.9M | -4.7x | --- |
Company Information
ASEP Medical Holdings Inc. is a Canada-based company, which is in the business of acquiring research and development assets, technologies and/or businesses in the area of life sciences and medical diagnostics. The Company’s consolidates three development-stage companies, including Sepset Biosciences Inc., ABT Innovations Inc., and SafeCoat Medical Inc. It provides medical devices with an anti-microbial, antifouling coating through its SafeCoat Medical Inc. The Company provides diagnostic kits for predicting the onset of severe Sepsis and organ failure through its Sepset Biosciences Inc. The Company also offers peptide technology through its ABT Innovations Inc. and covers a range of therapeutic applications, including bacterial biofilm infections, anti-inflammatories, anti-infective immune-modulators and vaccine adjuvants. SafeCoat Medical Inc.'s technology incorporates self-assembling biocompatible polymers combined with conjugated antimicrobial peptides.
Contact Information
- Headquarters
- 420 - 730 View StreetVICTORIA, BC, Canada V8W 3Y7
- Phone
- 778-600-0509
- Fax
- ---
Executives
- Chief Executive Officer, Director
- Robert Hancock
- Chief Financial Officer
- Jacqueline Tucker
- Chief Operating Officer, Company Secretary, Director
- Timothy Murphy
- Chief Science Officer
- Evan Haney
- Chief Business Development Officer
- Fadia Saad
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $4.5M |
|---|---|
Revenue (TTM) | $169.1K |
Shares Outstanding | 74.2M |
Asep Medical Holdings Inc does not pay a dividend. | |
Beta | --- |
EPS | $-0.08 |
Book Value | $0.17 |
P/E Ratio | -0.8x |
Price/Sales (TTM) | 26.3 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -3,646.71% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
